The hypercoagulable state in multiple myeloma: The contribution of thrombin generation test

Background Multiple myeloma is a hematologic malignancy which confers a high venous thromboembolic risk. This risk is linked to patient‐related factors, disease‐specific mechanisms, and antimyeloma therapy, especially immunomodulatory drugs. Some studies have suggested that the thrombin generation a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of laboratory hematology 2019-10, Vol.41 (5), p.684-690
Hauptverfasser:	Baccouche, Hela, Hadhri, Meriam, Aissi, Wafa, Chakroun, Aya, Bahri, Dhouha, Mahjoub, Sonia, Ben Romdhane, Neila
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - therapeutic use Blood Coagulation - drug effects Blood Coagulation Tests - methods Case-Control Studies coagulation Diagnosis Embolism Female Health risk assessment hemopathy hemostasis Humans Immunomodulation Male Malignancy Middle Aged monoclonal gammopathy Multiple myeloma Multiple Myeloma - blood Multiple Myeloma - drug therapy Multiple Myeloma - metabolism Patients Prospective Studies Thrombin Thrombin - metabolism Thromboembolism Thrombosis Thrombosis - blood Thrombosis - diagnosis Thrombosis - metabolism Velocity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!